Optimum nutrition: thiamin, biotin and pantothenate

被引:42
作者
Bender, DA [1 ]
机构
[1] Univ London Univ Coll, Dept Biochem & Mol Biol, London WC1E 6BT, England
关键词
thiamin status; biotin status; pantothenate status; transketolase activation; erythrocyte pyruvate carboxylase; 3-hydroxy-isovalerate excretion;
D O I
10.1017/S0029665199000567
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The metabolism of glucose is deranged in thiamin deficiency, but once any deficiency has been corrected there is no further effect of increased thiamin intake on the ability to metabolize glucose through either pyruvate dehydrogenase (EC 1.2.4.1) and the citric acid cycle, or the pentose phosphate pathway, in which transketolase (EC 2.2.1.1) is the thiamin-dependent step. It has been suggested that the Wernicke-Korsakoff syndrome is associated with a genetic variant of transketolase which requires a higher than normal concentration of thiamin diphosphate for activity. This finding would suggest that there may be a group of the population who have a higher than average requirement for thiamin, but the evidence is not convincing. There are no estimates of biotin requirements, but either coenzyme saturation of erythrocyte pyruvate carboxylase, or the excretion of 3-hydroxy-isovalerate (perhaps after a test dose of leucine) could be used to assess requirements in depletion-repletion studies. Biotin deficiency leads to impaired glucose tolerance, but it is unlikely that glucose tolerance could be used to assess optimum biotin status, since other more common factors affect glucose tolerance to a greater extent. Plasma triacylglycerol and nonesterified fatty acids are moderately elevated in pantothenic acid deficiency. However, this is unlikely to be useful in assessing pantothenate status, since again, other more common factors affect plasma lipids. To date there are no biochemical indices of adequate pantothenate nutrition, and no estimates of requirements.
引用
收藏
页码:427 / 433
页数:7
相关论文
共 65 条
[31]   ABNORMAL FATTY-ACID METABOLISM IN PATIENTS IN HOPANTENATE THERAPY DURING CLINICAL EPISODES [J].
MATSUMOTO, M ;
KUHARA, T ;
INOUE, Y ;
SHINKA, T ;
MATSUMOTO, I .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 562 (1-2) :139-145
[32]  
MATSUMOTO T, 1994, J NUTR, V124, P430
[33]  
MCCOOL BA, 1993, J BIOL CHEM, V268, P1397
[34]  
Meador K, 1993, J Geriatr Psychiatry Neurol, V6, P222
[35]   Thiamine therapy in Alzheimer's disease [J].
Mimori, Y ;
Katsuoka, H ;
Nakamura, S .
METABOLIC BRAIN DISEASE, 1996, 11 (01) :89-94
[36]  
MOCK DM, 1991, SEMIN DERMATOL, V10, P296
[37]   EFFECTS OF BIOTIN DEFICIENCY ON SERUM FATTY-ACID COMPOSITION - EVIDENCE FOR ABNORMALITIES IN HUMANS [J].
MOCK, DM ;
JOHNSON, SB ;
HOLMAN, RT .
JOURNAL OF NUTRITION, 1988, 118 (03) :342-348
[38]   BIOTIN DEFICIENCY IN RATS - DISTURBANCES OF LEUCINE METABOLISM ARE DETECTABLE EARLY [J].
MOCK, NI ;
MOCK, DM .
JOURNAL OF NUTRITION, 1992, 122 (07) :1493-1499
[39]   Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency [J].
Mock, NI ;
Malik, MI ;
Stumbo, PJ ;
Bishop, WP ;
Mock, DM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (04) :951-958
[40]   TRANSKETOLASE ABNORMALITY IN CULTURED FIBROBLASTS FROM FAMILIAL CHRONIC-ALCOHOLIC MEN AND THEIR MALE OFFSPRING [J].
MUKHERJEE, AB ;
SVORONOS, S ;
GHAZANFARI, A ;
MARTIN, PR ;
FISHER, A ;
ROECKLEIN, B ;
RODBARD, D ;
STATON, R ;
BEHAR, D ;
BERG, CJ ;
MANJUNATH, R .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1039-1043